1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

        <em id="8sgz1"><label id="8sgz1"></label></em>
      2. <em id="8sgz1"><label id="8sgz1"></label></em>
        <em id="8sgz1"></em>
        <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

        <button id="8sgz1"></button>
        west china medical publishers
        Keyword
        • Title
        • Author
        • Keyword
        • Abstract
        Advance search
        Advance search

        Search

        find Keyword "PICC" 12 results
        • Dexamethasone for Preventing PICC-Associated Phlebitis: A Systematic Review

          ObjectiveTo systematically review the effect of pre-treating the catheters with dexamethasone for preventing PICC-associated phlebitis. MethodsWe electronically searched PubMed, EMbase, The Cochrane Library (Issue 4, 2012), CNKI, CBM, WanFang Data and CQVIP for studies about pre-treating the catheters with dexamethasone to prevent PICC-associated phlebitis from inception to March 2013. Relevant studies including grey literature were also manually searched. Two reviewers independently screened studies according to the inclusion and exclusion criteria, extracted data and evaluated the methodological quality of the included studies. Then meta-analysis was performed using the software RevMan 5.0. ResultsA total of 13 studies involving 1 965 cases (1 025 cases in the dexamethasone group, and 940 cases in the control group) were included. The results of meta-analysis showed that pre-treating the catheters with dexamethasone could significantly decrease the incidence of PICC-associated phlebitis (RR=0.29, 95%CI=0.22 to 0.39, P < 0.000 1). However, no significant difference was found for the PICC-associated other complications, such as pipe blockage, bleeding, swelling of puncture site, allergy and atopic catheter. ConclusionPre-treating the catheters with dexamethasone soltion before inserting could reduce the incidence of PICC-associated phlebitis. The aforementioned conclusion needs to be further validated by more high-quality and large-scale randomized controlled trials.

          Release date: Export PDF Favorites Scan
        • Influence of PICC Ultrasound Guidance on Elbow Puncture and Catheterization and Its Complications: A Systematic Review

          Objective To systematically evaluate the influence of PICC (peripherally inserted central catheter) ultrasound guidance on success rates and incidences of complications of elbow catheterization. Methods The Cochrane Library (Issue 3, 2012), Library of JBI evidence-based nursing center, MEDLINE, EMbase, CBM, VIP, CNKI and WanFang Data were searched for relevant studies to influence on success rates of puncture and catheterization and complications from upper arm placement of PICC ultrasound guidance as well as conventional PICC placement from inception to March, 2012. The data were extracted according to the inclusion and exclusion criteria by two reviewers, the quality of included studies was also evaluated. Meta-analysis was conducted using RevMan 5.1, or only descriptive analysis was conducted instead. Results Eleven randomized controlled trials, five clinical controlled trials and four cohort studies were included, involving 4 052 patients. The results of meta-analysis showed that, upper arm placement of PICC ultrasound guidance combined with modified Seldinger technique was associated with significantly higher one-time success rates of puncture and catheterization than conventional PICC placement below the elbow, with significant differences (OR=4.71, 95%CI 1.97 to 11.28, P=0.000 5; OR=8.63, 95%CI 1.92 to 38.82, P=0.005). Conventional elbow catheterization had a significantly higher incidence of phlebitis than catheterization on the elbow that under the guidance of PICC ultrasound and modified Seldinger technique (OR=0.13, 95%CI 0.08 to 0.21, Plt;0.000 01). Conclusion Elbow catheterization under the guidance of PICC ultrasound combined with modified Seldinger technique has an obvious advantage in improving the success rates of puncture and catheterization and reducing the incidence of complications, compared with conventional elbow catheterization.

          Release date: Export PDF Favorites Scan
        • Efficacy of pulse indicating continuous cardiac output monitoring on the treatment guidance of patients with septic shock: a meta-analysis

          ObjectiveTo systematically review the efficacy of pulse indicating continuous cardiac output (PICCO) monitoring for guiding the treatment of patients with septic shock.MethodsDatabases including PubMed, The Cochrane Library, EMbase, Web of Science, CBM, WanFang Data, VIP and CNKI were electronically searched from inception to February 2017 to collect randomized controlled trials (RCTs) about PICCO monitoring on treatment guidance of patients with septic shock. Two reviewers independently screened literature, extracted data and assessed the risk of bias of included studies. Then meta-analysis was performed using Stata 12.0 software.ResultsA total of 20 RCTs involving 1 253 patients were included. The results of meta-analysis showed: compared with central venous pressure (CVP) measurements, the treatment of sepsis bundles informed by PICCO could significantly shorten the length of intensive care unit (ICU) stay (MD=–2.74, 95%CI –3.40 to –2.09, P<0.001), reduce the ICU mortality (RR=0.49, 95%CI 0.36 to 0.67, P<0.001) and 28-day mortality (RR=0.61, 95%CI 0.43 to 0.87, P=0.006).ConclusionCurrent evidence shows the PICCO monitoring can significantly improve the prognosis of septic shock. Due to limited and quantity quality of the included studies, more high-quality studies are needed to verify above conclusion.

          Release date:2017-08-17 10:28 Export PDF Favorites Scan
        • Establishment of risk factors and risk nomogram model for unplanned extubation during peripherally inserted central catheter retention in cancer patients

          ObjectiveTo retrospectively analyze the causes and risk factors of unplanned extubation (UE) in cancer patients during peripherally inserted central catheter (PICC) retention, so as to provide references for effectively predicting the occurrence of UE. Methods27 998 cancer patients who underwent PICC insertion, maintenance and removal in the vascular access nursing center of our hospital from January 2016 to June 2023 were retrospectively analyzed. General information, catheterization information, and maintenance information were collected. The Chi-squared test was used for univariate analysis, multivariate analysis was used by binary unconditional logistic regression. They were randomly divided into modeling group and internal validation group according to the ratio of 7∶3. The related nomogram prediction model and internal validation were established. ResultsThe incidence of UE during PICC retention in tumor patients was 2.80% (784/27 998 cases). Univariate analysis showed that age, gender, diagnosis, catheter retention time, catheter slipping, catheter related infection, catheter related thrombosis, secondary catheter misplacement, dermatitis, and catheter blockage had an impact on UE (P<0.05). Age, diagnosis, catheter retention time, catheter slipping, catheter related infection, catheter related thrombosis, secondary catheter misplacement, and catheter blockage are independent risk factors for UE (P<0.05). Based on the above 8 independent risk factors, a nomogram model was established to predict the risk of UE during PICC retention in tumor patients. The ROC area under the predicted nomogram was 0.90 (95%CI 0.89 to 0.92) in the modeling group, and the calibration curve showed good predictive consistency. Internal validation showed that the area under the ROC curve of the prediction model was 0.91 (95%CI 0.89 to 0.94), and the trend of the prediction curve was close to the standard curve. ConclusionPatients aged ≥60 years, non chest tumor patients, catheter retention time (≤6 months), catheter slipping, catheter related infections, catheter related thrombosis, secondary catheter misplacement, and catheter blockage increase the risk of UE. The nomogram model established in this study has good predictive ability and discrimination, which is beneficial for clinical screening of patients with different degrees of risk, in order to timely implement targeted prevention and effective treatment measures, and ultimately reduce the occurrence of UE.

          Release date:2025-01-21 09:54 Export PDF Favorites Scan
        • 康惠爾水膠體透明貼用于腫瘤患者PICC置管術后的護理研究

          目的:觀察康惠爾水膠體透明貼用于PICC置管術后靜脈炎預防的效果。方法:將126例PICC置管的患者隨機分為實驗組61例,對照組65例。實驗組從置管當日開始使用康惠爾水膠體透明貼,對照組從置管當日用3M透明敷貼,觀察兩組靜脈炎的發生率。結果:實驗組61例患者無一例發生靜脈炎,對照組65例患者有4例發生靜脈炎,統計學上有顯著性差異(P<0.05)。結論:康惠爾水膠體透明貼在預防靜脈炎方面有明顯的效果,PICC置管時首選貴要靜脈可明顯降低靜脈炎的發生率。

          Release date:2016-09-08 10:01 Export PDF Favorites Scan
        • 水膠體敷料用于PICC置管后局部皮膚的觀察

          目的:了解不同水膠體敷料用于PICC置管術后穿刺局部皮膚過敏的發生情況。 方法: 將PICC置管患者隨機分為水膠體敷料組及透明敷貼組,實驗組穿刺局部皮膚使用水膠體敷料,對照組常規使用3 M透明敷貼,比較兩組患者穿刺局部皮膚過敏的發生率。 結果: 水膠體敷料組患者局部皮膚過敏的發生率(3.3%)低于3M透明敷貼組(24.1%)(P<0.05)。 結論: 水膠體敷料用于PICC置管術后穿刺局部皮膚的固定皮膚過敏的發生率低于3 M透明敷貼組。

          Release date:2016-08-26 02:21 Export PDF Favorites Scan
        • 尿激酶在腫瘤化療患者間歇期外周靜脈置入中心靜脈導管封管維護的臨床應用

          【摘要】 目的 〖JP2〗總結腫瘤患者化療間歇期外周置入中心靜脈導管(PICC)后封管維護的方法和效果。 方法 2010年1-5月應用0.5 mL含尿激酶12.5萬U的生理鹽水代替常規肝素封管液, 對PICC管行封管維護,使PICC管在患者整個化療間歇期保持通暢。 結果 通過對13例32次PICC管尿激酶封管顯示,尿激酶封管能維持PICC管通暢長達23 d,平均15 d,通暢率達93.7%,無感染無出血發生,患者封管前后檢測外周血出凝血(DIC)各項指標變化無統計學差異。 結論 腫瘤患者化療間歇期,尿激酶封管能維持PICC管通暢,經檢測對患者出凝血系統無影響,無不良反應。

          Release date:2016-09-08 09:52 Export PDF Favorites Scan
        • The Role of Heparin in Prevention of Neonatal Catheter-related Complications in Peripherally Inserted Central Catheters

          Objective?To investigate the role of low-dose heparin added to total nutrient admixture (TNA) solutions in the prevention of catheter related infections (CRIs). Methods?One-hundred three newborn infants with periph-erally inserted central catheter (PICC) were divided into heparin group (n=63) and control group (n=40). The patients in the heparin group received TNA with 0.5 U/ ml heparin. The patients in the control group received TNA without heparin. We retrospectively analyzed the incidence of CRTs in the two groups. Results?We found that the incidence of CRIs was 0 in the heparin group and 12.5% (5/40) in the control group. The incidence of catheter obstruction was 6.3% (4/63) in the heparin group and 20% (8/40) in the control group. The incidence of catheter-tip colonization was 1.58% (1/40) in the heparin group and 17.5% (7/40) in the control group. The incidences of CRIs, catheter obstruction, and catheter-tip colonization were signiicantly lower in the heparin group than those in the control group (Plt;0.05). Conclusion?TNA solutions with 0.5U/ml heparin have decreased catheter obstruction and CRIs.

          Release date:2016-09-07 11:24 Export PDF Favorites Scan
        • 經外周置入中心靜脈導管致過敏性皮炎的防治進展

          經外周置入中心靜脈導管(peripheral inserted central catheter, PICC)由于其具有使用安全、方便,保留時間長(可達1年),同時可以避免患者反復靜脈穿刺帶來的痛苦及化療性靜脈炎等優點已廣泛應用于臨床。在PICC導管長時間的留置過程中,需要反復換藥,穿刺點周圍皮膚易出現潮紅、瘙癢、濕疹樣小水泡甚至破裂。其發生的相關因素有內源性因素和多種外源性因素(PICC導管,透明敷貼,消毒劑)。提出合理選擇和使用PICC導管、透明敷貼,消毒劑,嚴格執行操作規范,靈活掌握透明敷貼的更換時間,提高患者自護意識,可預防過敏性皮炎發生;一旦發生過敏性皮炎可局部使用氧化鋅軟膏或地塞米松 + 慶大霉素等換藥,可促進過敏性皮炎痊愈。

          Release date:2016-09-08 09:56 Export PDF Favorites Scan
        • 對外周靜脈置入中心靜脈導管堵塞使用肝素鈉注射液再通的應用與效果

          【摘要】 目的 總結外周靜脈置入中心靜脈導管(peripherally inserted central catheter,PICC)使用肝素鈉注射液聯合三通接頭負壓實現再疏通的方法與效果。 方法 2009年8月-2010年11月,對8例腫瘤患者因置入的PICC導管發生血栓性堵塞,采用肝素鈉注射液聯合三通接頭進行抽吸、負壓注射再疏通的方法進行回顧分析。 結果 8例患者PICC導管堵塞均再通成功,未出現任何不適,有效地避免了拔插管事件的發生,使患者順利完成后期治療。 結論 使用肝素鈉注射液聯合三通接頭負壓處置PICC導管堵塞,方法簡便,再通效率高,效果良好。

          Release date:2016-09-08 09:25 Export PDF Favorites Scan
        2 pages Previous 1 2 Next

        Format

        Content

          1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

            <em id="8sgz1"><label id="8sgz1"></label></em>
          2. <em id="8sgz1"><label id="8sgz1"></label></em>
            <em id="8sgz1"></em>
            <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

            <button id="8sgz1"></button>
            欧美人与性动交α欧美精品